Long-term safety and clinical effects of riociguat in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: Interim analysis of a phase II extension study
H. A. Ghofrani, M. M. Hoeper, M. Halank, F. J. Meyer, G. Staehler, J. Behr, R. Ewert, T. Binnen, G. Weimann, F. Grimminger, on Behalf of the Study Investigators (Hannover, Dresden, Heidelberg, Greifswald, Leverkusen, Wuppertal, Germany)
Source: Annual Congress 2010 - Pulmonary hypertension updates
Session: Pulmonary hypertension updates
Session type: Oral Presentation
Number: 1913
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. A. Ghofrani, M. M. Hoeper, M. Halank, F. J. Meyer, G. Staehler, J. Behr, R. Ewert, T. Binnen, G. Weimann, F. Grimminger, on Behalf of the Study Investigators (Hannover, Dresden, Heidelberg, Greifswald, Leverkusen, Wuppertal, Germany). Long-term safety and clinical effects of riociguat in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: Interim analysis of a phase II extension study. Eur Respir J 2010; 36: Suppl. 54, 1913
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: